TGFB1 and breast carcinoma: This discord in pSMAD2 upregulation following SHP2 inhibition was similarly observed in the breast cancer cell lines MDA-MB-436 and BT474, suggesting that the SHP2 effect on TGFβ signalling is nuanced and likely influenced by multiple factors (Supplementary Fig. 3a–d).